Your session is about to expire
← Back to Search
Behavioural Intervention
Telemedicine Consultation for Alcoholism (ATC Trial)
N/A
Waitlist Available
Led By Stacy A Sterling, DrPh
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
ATC Trial Summary
This trial will examine how well an innovative, multi-faceted intervention using clinical pharmacists to facilitate alcohol use problems and alcohol use disorder (AUD) pharmacotherapy and specialty addiction treatment entry works.
Who is the study for?
This trial is for adult members of the KPNC who visited primary care in Oakland or San Francisco between 2020 and 2021. It includes around 250,000 patients, about 300 primary care providers (PCPs), chief physicians, PCPs, and medical assistants at intervention clinics.Check my eligibility
What is being tested?
The ATC Intervention is being tested to see if clinical pharmacists can help with alcohol use problems and encourage entry into specialty addiction treatment through a telemedicine consultant service.See study design
What are the potential side effects?
Since this trial focuses on a consultation service rather than medication or procedures, there are no direct side effects from the intervention itself.
ATC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
AUD Medication Fills
Addiction Treatment Initiation Rate
Alcohol use (quantity/frequency)
+4 moreATC Trial Design
2Treatment groups
Active Control
Group I: ATC Service (intervention)Active Control1 Intervention
ATC components include in-exam-room, real-time videoconferencing or phone contact with the PCPs and their patients, asynchronous, rapid response consultation via email or phone. ATC consultants will offer a flexible service that includes:
Direct patient contact, via video or telephone, during primary care visits
Motivational Interviewing (MI) - informed facilitation of patient engagement in addiction treatment,
Advice to PCP regarding patient-specific treatment options, including pharmacotherapy, addiction treatment, and combined treatments
Group II: Usual CareActive Control1 Intervention
Usual Care (UC) will consist of treatment as usual, standard and systematic alcohol screening as part of the "rooming" process conducted by medical assistants, and brief interventions and referrals to addiction treatment delivered by PCPs. PCPs can also prescribe the same AUD medications as those in the ATC arm.
Find a Location
Who is running the clinical trial?
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
811 Previous Clinical Trials
1,116,444 Total Patients Enrolled
428 Trials studying Alcoholism
736,514 Patients Enrolled for Alcoholism
Kaiser PermanenteLead Sponsor
541 Previous Clinical Trials
23,865,273 Total Patients Enrolled
6 Trials studying Alcoholism
1,084,622 Patients Enrolled for Alcoholism
Stacy A Sterling, DrPhPrincipal InvestigatorKaiser Permanente
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: ATC Service (intervention)
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger